In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Immune Response receives two U.S. patents
ImmunoVaccine Technologies Broadens Its Patent Protection to Japan
Immune Response Corporation not to proceed with HIV study
The Immune Response Corporation announces payment from Agouron Pharmaceuticals
Immune Response licenses Hybridon's 2nd-generation CpG DNA adjuvant
Immune Response announces restructuring of license agreement
U.S. Patent and Trademark Office issues cancer vaccine patent
Immune Response acquires T cell receptor technology
Immune Response reaches agreement with Maryland Biotech Institute